ENALAPRILAT, AN INTRAVENOUS ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, IN HYPERTENSIVE CRISES

被引:34
作者
DIPETTE, DJ
FERRARO, JC
EVANS, RR
MARTIN, M
机构
关键词
D O I
10.1038/clpt.1985.159
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:199 / 204
页数:6
相关论文
共 27 条
[2]   MECHANISM OF DETERIORATION IN RENAL-FUNCTION IN PATIENTS WITH RENOVASCULAR HYPERTENSION TREATED WITH ENALAPRIL [J].
BENDER, W ;
LAFRANCE, N ;
WALKER, WG .
HYPERTENSION, 1984, 6 (02) :I193-I197
[3]   HYPERTENSIVE CRISIS TREATED WITH ORALLY-ADMINISTERED CAPTOPRIL [J].
BIOLLAZ, J ;
WAEBER, B ;
BRUNNER, HR .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 25 (02) :145-149
[4]   CONVERTING ENZYME-INHIBITION WITH AN ORALLY ACTIVE COMPOUND IN HYPERTENSIVE MAN [J].
BRAVO, EL ;
TARAZI, RC .
HYPERTENSION, 1979, 1 (01) :39-46
[5]   CLINICAL EXPERIENCE WITH BLOCKADE OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM BY AN ORAL CONVERTING-ENZYME INHIBITOR (SQ 14,225, CAPTOPRIL) IN HYPERTENSIVE PATIENTS [J].
CASE, DB ;
ATLAS, SA ;
LARAGH, JH ;
SEALEY, JE ;
SULLIVAN, PA ;
MCKINSTRY, DN .
PROGRESS IN CARDIOVASCULAR DISEASES, 1978, 21 (03) :195-206
[6]   ACUTE AND CHRONIC TREATMENT OF SEVERE AND MALIGNANT HYPERTENSION WITH THE ORAL ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR CAPTOPRIL [J].
CASE, DB ;
ATLAS, SA ;
SULLIVAN, PA ;
LARAGH, JH .
CIRCULATION, 1981, 64 (04) :765-771
[7]   RACIAL-DIFFERENCES IN PRESSURE, VOLUME AND RENIN INTERRELATIONSHIPS IN ESSENTIAL HYPERTENSION [J].
CHRYSANT, SG ;
DANISA, K ;
KEM, DC ;
DILLARD, BL ;
SMITH, WJ ;
FROHLICH, ED .
HYPERTENSION, 1979, 1 (02) :136-141
[8]   BLINDNESS AFTER TREATMENT FOR MALIGNANT HYPERTENSION [J].
COVE, DH ;
SEDDON, M ;
FLETCHER, RF ;
DUKES, DC .
BRITISH MEDICAL JOURNAL, 1979, 2 (6184) :245-246
[9]   ACUTE REGIONAL CIRCULATORY AND RENAL HEMODYNAMIC-EFFECTS OF CONVERTING-ENZYME INHIBITION IN PATIENTS WITH CONGESTIVE HEART-FAILURE [J].
CREAGER, MA ;
HALPERIN, JL ;
BERNARD, DB ;
FAXON, DP ;
MELIDOSSIAN, CD ;
GAVRAS, H ;
RYAN, TJ .
CIRCULATION, 1981, 64 (03) :483-489
[10]  
GAVRAS H, 1981, LANCET, V2, P543